{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05406232",
            "orgStudyIdInfo": {
                "id": "2021-0669"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2021-09773",
                    "type": "REGISTRY",
                    "domain": "CTRP (Clinical Trial Reporting Program)"
                },
                {
                    "id": "2021-0669",
                    "type": "OTHER",
                    "domain": "M D Anderson Cancer Center"
                }
            ],
            "organization": {
                "fullName": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer",
            "officialTitle": "Quantifying Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "temporal-immunologic-changes-with-hypofractionated-radiation-induced-dna-damage-in-breast-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-09-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-06-01",
            "studyFirstSubmitQcDate": "2022-06-01",
            "studyFirstPostDateStruct": {
                "date": "2022-06-06",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-25",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This study assesses changes to the immune cells following hypofractionated radiation-induced DNA damage in breast cancer patients. Radiation therapy may cause immune cells to enter tumors and target cancer cells. The goal of this study is to measure the change in the level of immune cells in the tumor before and after radiation therapy.",
            "detailedDescription": "PRIMARY OBJECTIVE:\n\nI. To estimate the percent change in immune infiltration at day 3 and day 7 of radiotherapy (RT) relative to baseline (before radiotherapy).\n\nSECONDARY OBJECTIVE:\n\nI. To estimate the degree of deoxyribonucleic acid (DNA) damage at approximately 3 and 7 days after radiotherapy compared to baseline.\n\nII. To examine cancer cell intrinsic immune signaling following radiotherapy.\n\nEXPLORATORY OBJECTIVE:\n\nI. To examine the association between DNA damage and micronuclei formation. II. To examine the association between DNA damage and immune infiltration. III. To examine the association between micronuclei formation and immune infiltration.\n\nOUTLINE:\n\nPatients undergo RT on day 1. Patients also undergo tumor punch biopsies and blood sample collection prior to the first fraction and on days 1, 3, and 7."
        },
        "conditionsModule": {
            "conditions": [
                "Breast Carcinoma",
                "Invasive Breast Carcinoma"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITH_DNA",
                "description": "Tissue, blood"
            },
            "enrollmentInfo": {
                "count": 12,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Observational (RT, biopsy)",
                    "description": "Patients undergo RT on day 1. Patients also undergo tumor punch biopsies and blood sample collection prior to the first fraction and on days 1, 3, and 7.",
                    "interventionNames": [
                        "Procedure: Biopsy",
                        "Procedure: Biospecimen Collection",
                        "Radiation: Radiation Therapy"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "PROCEDURE",
                    "name": "Biopsy",
                    "description": "Undergo tumor punch biopsy",
                    "armGroupLabels": [
                        "Observational (RT, biopsy)"
                    ],
                    "otherNames": [
                        "BIOPSY_TYPE",
                        "Bx"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Biospecimen Collection",
                    "description": "Undergo blood sample collection",
                    "armGroupLabels": [
                        "Observational (RT, biopsy)"
                    ],
                    "otherNames": [
                        "Biological Sample Collection",
                        "Biospecimen Collected"
                    ]
                },
                {
                    "type": "RADIATION",
                    "name": "Radiation Therapy",
                    "description": "Undergo RT",
                    "armGroupLabels": [
                        "Observational (RT, biopsy)"
                    ],
                    "otherNames": [
                        "Cancer Radiotherapy",
                        "ENERGY_TYPE",
                        "Irradiate",
                        "Irradiated",
                        "Irradiation",
                        "Radiation",
                        "Radiation Therapy, NOS",
                        "Radiotherapeutics",
                        "Radiotherapy",
                        "RT",
                        "Therapy, Radiation"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "To estimate the percent change in immune infiltration.",
                    "description": "Will be estimated with corresponding two-sided 80% confidence intervals. Also, marker levels at each time point and unstandardized effect sizes (arithmetic differences from baseline) across time points will be estimated along with 2-sided 80% confidence intervals.",
                    "timeFrame": "Baseline up to day 7"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients \\>= 18 years of age with biopsy proven invasive breast cancer\n* Breast cancer that appears to be superficially accessible to a tumor punch biopsy\n* Patients thought to derive clinical benefit from palliative RT to the breast/chestwall\n* In discussions with the medical oncologist, if clinically reasonable, systemic therapy will be held during RT\n\nExclusion Criteria:\n\n* A history of prior radiation to the area requiring radiation for which the attending physician believes reirradiation could not be safely delivered\n* Pregnancy\n* Active usage of anticoagulant medications that are considered to pose an increased risk of tumor punch biopsies\n* Receipt of immunotherapy or chemotherapy 7 days prior to start of RT",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Patients with breast cancer that appears to be superficially accessible to a tumor punch biopsy",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Simona F Shaitelman, MD",
                    "role": "CONTACT",
                    "phone": "(713) 563-8491",
                    "email": "sfshaitelman@mdanderson.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Simona F Shaitelman, MD",
                    "affiliation": "M.D. Anderson Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "M D Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Simona F. Shaitelman, MD",
                            "role": "CONTACT",
                            "phone": "713-563-8491",
                            "email": "sfshaitelman@mdanderson.org"
                        },
                        {
                            "name": "Simona F. Shaitelman, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "MD Anderson Cancer Center",
                    "url": "http://www.mdanderson.org"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000001943",
                    "term": "Breast Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000001941",
                    "term": "Breast Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "asFound": "Breast Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "asFound": "Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M5218",
                    "name": "Breast Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}